close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >
Does an FDA Fast Track Designation Make Regenxbio Stock a Buy Now?
Tickers RGNX
Tags Market News RGNX Recent Press Releases
From Motley Fool
Tesla To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Monday
Tickers BIG DHI GBIO HIBB
Tags BIG PT Changes HIBB
From Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
Tickers AMPH AMPY BGS BLNK
Tags AMPY RETA SDGR
From Benzinga
Earnings Scheduled For February 28, 2023
Tickers NFE NNI NRDY NSTG
Tags SRE SWX PETQ
From Benzinga
Earnings Preview: Regenxbio
Tickers RGNX
Tags BZI/EP Market News Benzinga
From Benzinga
Looking Into Regenxbio's Return On Capital Employed
Tickers RGNX
Tags BZI/ROCE RGNX Market News
From Benzinga
5 Analysts Have This to Say About Regenxbio
Tickers RGNX
Tags Analyst Ratings Market News Benzinga
From Benzinga
What 5 Analyst Ratings Have To Say About Regenxbio
Tickers RGNX
Tags BZI/AAR Analyst Ratings Benzinga
From Benzinga
Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
Tickers RGNX
Tags Small Cap Market News Benzinga
From Benzinga
Recap: Regenxbio Q3 Earnings
Tickers RGNX
Tags Earnings Benzinga Market News
From Benzinga
Earnings Scheduled For November 3, 2022
Tickers PWP PWR PYPL PZZA
Tags UONEK UONE XPRO
From Benzinga
Regenxbio's Earnings Outlook
Tickers RGNX
Tags BZI/EP RGNX Market News
From Benzinga
Despite Solid Efficacy From Gene Therapy, This Analyst Cuts REGENXBIO's Price Target
Tickers RGNX
Tags Small Cap Market News Benzinga
From Benzinga
Alphabet To $114? Plus This Analyst Predicts $145 For Disney
Tickers ACCD BKR COMM DIS
Tags DIS Markets RGNX
From Benzinga
What 4 Analyst Ratings Have To Say About Regenxbio
Tickers RGNX
Tags BZI/AAR Benzinga Market News
From Benzinga
4 Analysts Have This to Say About Regenxbio
Tickers RGNX
Tags BZI/AAR RGNX Market News
From Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
Tickers ALNY GKOS LABP MACK
Tags Biotech Catalysts / EOD Summary Small Cap Penny Stocks
From Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags PSTX Market News Benzinga
From Benzinga
Regenxbio's Earnings Outlook
Tickers RGNX
Tags Earnings Benzinga Market News
From Benzinga
Expert Ratings for Regenxbio
Tickers RGNX
Tags BZI/AAR Analyst Ratings RGNX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
Tickers AAP ADC ADXN AEIS
Tags CMI DNLI AVB
From Benzinga
5 Small-Cap S&P Stocks To Buy With The Most Upside
Tickers AXL CYH RGNX TGI
Tags John Murphy Market News Benzinga
From Benzinga
Regenxbio's Return On Capital Employed Overview
Tickers RGNX
Tags BZI/ROCE RGNX Benzinga
From Benzinga
Expert Ratings for Regenxbio
Tickers RGNX
Tags Benzinga Market News RGNX
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Tickers ABEO AGTC AKTX AMPE
Tags PTE AKTX Small Cap
From Benzinga
5 Value Stocks In The Healthcare Sector
Tickers CO ITOS NVS RGNX
Tags WBA Benzinga NVS
From Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Tickers ATNX AVRO AXDX BHVN
Tags IPOs Earnings SYRS
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACRX AHCO BCDA BTTX
Tags Benzinga Market News HSTO
From Benzinga
83 Biggest Movers From Yesterday
Tickers AENZ AIKI ALB ALNA
Tags CZOO Trading Ideas WTER
From Benzinga
57 Stocks Moving In Thursday's Mid-Day Session
Tickers AIKI ALB APPH ASAN
Tags EPAM CASA SFM
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today